Acidom (170 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Sienna Formulations Pvt Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Aluminium Hydroxide, Magnesium Hydrochloride,Oxetacaine. This drug comes in the form of Suspension. The general packing available for this medicine consists of 170 ml and is priced at Rs 54.8 (arround $0.7672 US Dollar)
The main active ingredients or salts in Acidom (170 ml) are :
Oxetacaine-10 mg
Aluminium Hydroxide-291 mg
Magnesium Hydrochloride-98 mg
Aluminium Hydroxide Indication (Prescribed for or used as):
For more details on Aluminium Hydroxide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Aluminium Hydroxide..
Magnesium Hydrochloride Indication (Prescribed for or used as):
For more details on Magnesium Hydrochloride, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Magnesium Hydrochloride..
Oxetacaine Indication (Prescribed for or used as): Local anaesthetic. It is used in combination with antacids for relief of pain in oesophagitis or acid peptic disease Topical application in hemorrhoid.
For more details on Oxetacaine, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Oxetacaine..
Acidom (170 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Acidom (170 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Oxetacaine-10 mg Aluminium Hydroxide-291 mg Magnesium Hydrochloride-98 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.